col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

Springer (Biomed Central Ltd.): BMC Medicine
  original article Date Title Authors   All Authors
1 [GO] 2021―Jul―28 Evaluation of the safety profile of COVID-19 vaccines: a rapid review Qianhui Wu, Matthew Z. Dudley, Xinghui Chen, Xufang Bai, Kaige Dong, Tingyu Zhuang, et al. (+2)
2 [GO] 2021―Jul―26 Humoral immune responses during SARS-CoV-2 mRNA vaccine administration in seropositive and seronegative individuals Elizabeth Fraley, Cas LeMaster, Eric Geanes, Dithi Banerjee, Santosh Khanal, Elin Grundberg, et al. (+2)
3 [GO] 2021―Jul―14 Dynamic changes of functional fitness, antibodies to SARS-CoV-2 and immunological indicators within 1 year after discharge in Chinese health care workers with severe COVID-19: a cohort study Lijuan Xiong, Qian Li, Xiongjing Cao, Huangguo Xiong, Ming Huang, Fengwen Yang, et al. (+14)
4 [GO] 2021―Jul―13 Optimal SARS-CoV-2 vaccine allocation using real-time attack-rate estimates in Rhode Island and Massachusetts Thu Nguyen-Anh Tran, Nathan B. Wikle, Emmy Albert, Haider Inam, Emily Strong, Karel Brinda, et al. (+8)
5 [GO] 2021―Jul―09 The East African Community (EAC) mobile laboratory networks in Kenya, Burundi, Tanzania, Rwanda, Uganda, and South Sudan-from project implementation to outbreak response against Dengue, Ebola, COVID-19, and epidemic-prone diseases Muna Affara, Hakim Idris Lagu, Emmanuel Achol, Richard Karamagi, Neema Omari, Grace Ochido, et al. (+30)
6 [GO] 2021―Jun―28 Persistence and baseline determinants of seropositivity and reinfection rates in health care workers up to 12.5 months after COVID-19 Carlota Dobaño, Anna Ramírez-Morros, Selena Alonso, Josep Vidal-Alaball, Gemma Ruiz-Olalla, Marta Vidal, et al. (+12)
7 [GO] 2021―Jun―23 Relation of severe COVID-19 in Scotland to transmission-related factors and risk conditions eligible for shielding support: REACT-SCOT case-control study Paul M. McKeigue, David A. McAllister, David Caldwell, Ciara Gribben, Jen Bishop, Stuart McGurnaghan, et al. (+9)
8 [GO] 2021―Jun―18 Using syndromic measures of mortality to capture the dynamics of COVID-19 in Java, Indonesia, in the context of vaccination rollout Bimandra A. Djaafara, Charles Whittaker, Oliver J. Watson, Robert Verity, Nicholas F. Brazeau, Dwi Oktavia, et al. (+16)
9 [GO] 2021―Jun―07 An analysis of school absences in England during the COVID-19 pandemic Emma Southall, Alex Holmes, Edward M. Hill, Benjamin D. Atkins, Trystan Leng, Robin N. Thompson, et al. (+3)
10 [GO] 2021―Jun―04 Renin-angiotensin system blockers and COVID-19 Emmanuelle Vidal-Petiot, Nathalie Gault
11 [GO] 2021―May―20 Sequelae, persistent symptomatology and outcomes after COVID-19 hospitalization: the ANCOHVID multicentre 6-month follow-up study Álvaro Romero-Duarte, Mario Rivera-Izquierdo, Inmaculada Guerrero-Fernández de Alba, Marina Pérez-Contreras, Nicolás Francisco Fernández-Martínez, Rafael Ruiz-Montero, et al. (+5)
12 [GO] 2021―May―17 Impact of COVID-19 lockdown on the incidence and mortality of acute exacerbations of chronic obstructive pulmonary disease: national interrupted time series analyses for Scotland and Wales Mohammad A. Alsallakh, Shanya Sivakumaran, Sharon Kennedy, Eleftheria Vasileiou, Ronan A. Lyons, Chris Robertson, et al. (+2)
13 [GO] 2021―May―12 Impact of in-hospital discontinuation with angiotensin receptor blockers or converting enzyme inhibitors on mortality of COVID-19 patients: a retrospective cohort study Francisco J. de Abajo, Antonio Rodríguez-Miguel, Sara Rodríguez-Martín, Victoria Lerma, Alberto García-Lledó
14 [GO] 2021―May―07 Comparison of infection control strategies to reduce COVID-19 outbreaks in homeless shelters in the United States: a simulation study Lloyd A. C. Chapman, Margot Kushel, Sarah N. Cox, Ashley Scarborough, Caroline Cawley, Trang Q. Nguyen, et al. (+4)
15 [GO] 2021―Apr―29 What neurological and psychiatric effects does COVID-19 have on its survivors? Alexios-Fotios A. Mentis
16 [GO] 2021―Apr―27 Estimating the effectiveness of routine asymptomatic PCR testing at different frequencies for the detection of SARS-CoV-2 infections Joel Hellewell, Timothy W. Russell, Rupert Beale, Gavin Kelly, Catherine Houlihan, Eleni Nastouli, Adam J. Kucharski
17 [GO] 2021―Apr―14 Reducing travel-related SARS-CoV-2 transmission with layered mitigation measures: symptom monitoring, quarantine, and testing Michael A. Johansson, Hannah Wolford, Prabasaj Paul, Pamela S. Diaz, Tai-Ho Chen, Clive M. Brown, et al. (+2)
18 [GO] 2021―Apr―09 Modeling the interplay between demography, social contact patterns, and SARS-CoV-2 transmission in the South West Shewa Zone of Oromia Region, Ethiopia Filippo Trentini, Giorgio Guzzetta, Margherita Galli, Agnese Zardini, Fabio Manenti, Giovanni Putoto, et al. (+8)
19 [GO] 2021―Mar―24 Greater public health impact of COVID-19 antigen detection tests Akiko Kowada
20 [GO] 2021―Mar―24 Evaluation of glycemic traits in susceptibility to COVID-19 risk: a Mendelian randomization study Shiu Lun Au Yeung, Jie V Zhao, C Mary Schooling
21 [GO] 2021―Mar―09 Quantifying the potential value of antigen-detection rapid diagnostic tests for COVID-19: a modelling analysis Saskia Ricks, Emily A. Kendall, David W. Dowdy, Jilian A. Sacks, Samuel G. Schumacher, Nimalan Arinaminpathy
22 [GO] 2021―Mar―05 Excess mortality for care home residents during the first 23 weeks of the COVID-19 pandemic in England: a national cohort study Marcello Morciano, Jonathan Stokes, Evangelos Kontopantelis, Ian Hall, Alex J. Turner
23 [GO] 2021―Feb―23 Following the science? Comparison of methodological and reporting quality of covid-19 and other research from the first wave of the pandemic Terence J. Quinn, Jennifer K. Burton, Ben Carter, Nicola Cooper, Kerry Dwan, Ryan Field, et al. (+9)
24 [GO] 2021―Feb―22 Relation of severe COVID-19 to polypharmacy and prescribing of psychotropic drugs: the REACT-SCOT case-control study Paul M. McKeigue, Sharon Kennedy, Amanda Weir, Jen Bishop, Stuart J. McGurnaghan, David McAllister, et al. (+11)
25 [GO] 2021―Feb―20 Exit strategies: optimising feasible surveillance for detection, elimination, and ongoing prevention of COVID-19 community transmission K. Lokuge, E. Banks, S. Davis, L. Roberts, T. Street, D. O’Donovan, et al. (+2)
26 [GO] 2021―Feb―20 The impact of local and national restrictions in response to COVID-19 on social contacts in England: a longitudinal natural experiment Christopher I. Jarvis, Amy Gimma, Kevin van Zandvoort, Kerry L. M. Wong, W. John Edmunds
27 [GO] 2021―Feb―10 Who should be prioritized for COVID-19 vaccination in China? A descriptive study Juan Yang, Wen Zheng, Huilin Shi, Xuemei Yan, Kaige Dong, Qian You, et al. (+7)
28 [GO] 2021―Feb―05 COVID-19 pandemic and violence: rising risks and decreasing urgent care-seeking for sexual assault and domestic violence survivors Katherine A. Muldoon, Kathryn M. Denize, Robert Talarico, Deshayne B. Fell, Agnes Sobiesiak, Melissa Heimerl, Kari Sampsel
29 [GO] 2021―Feb―05 The impact of non-pharmaceutical interventions on SARS-CoV-2 transmission across 130 countries and territories Yang Liu, Christian Morgenstern, James Kelly, Rachel Lowe, Mark Jit
30 [GO] 2021―Feb―03 The importance of supplementary immunisation activities to prevent measles outbreaks during the COVID-19 pandemic in Kenya C. N. Mburu, J. Ojal, R. Chebet, D. Akech, B. Karia, J. Tuju, et al. (+12)
31 [GO] 2021―Jan―28 When a pandemic and an epidemic collide: COVID-19, gut microbiota, and the double burden of malnutrition Paula Littlejohn, B. Brett Finlay
32 [GO] 2021―Jan―28 Development of the reproduction number from coronavirus SARS-CoV-2 case data in Germany and implications for political measures Sahamoddin Khailaie, Tanmay Mitra, Arnab Bandyopadhyay, Marta Schips, Pietro Mascheroni, Patrizio Vanella, et al. (+3)
33 [GO] 2021―Jan―22 Efficient SARS-CoV-2 surveillance strategies to prevent deadly outbreaks in vulnerable populations Damon J. A. Toth, Karim Khader
34 [GO] 2021―Jan―21 Evaluation and improvement of the National Early Warning Score (NEWS2) for COVID-19: a multi-hospital study Ewan Carr, Rebecca Bendayan, Daniel Bean, Matt Stammers, Wenjuan Wang, Huayu Zhang, et al. (+42)
35 [GO] 2021―Jan―12 Potential impact of individual exposure histories to endemic human coronaviruses on age-dependent severity of COVID-19 Francesco Pinotti, Paul S. Wikramaratna, Uri Obolski, Robert S. Paton, Daniel S. C. Damineli, Luiz C. J. Alcantara, et al. (+3)
36 [GO] 2020―Dec―18 Cardiovascular implications of COVID-19 versus influenza infection: a review Muhammad Shahzeb Khan, Izza Shahid, Stefan D. Anker, Scott D. Solomon, Orly Vardeny, Erin D. Michos, et al. (+2)
37 [GO] 2020―Dec―18 Increased care at discharge from COVID-19: The association between pre-admission frailty and increased care needs after hospital discharge; a multicentre European observational cohort study A. Vilches-Moraga, A. Price, P. Braude, L. Pearce, R. Short, A. Verduri, et al. (+11)
38 [GO] 2020―Dec―17 Changes in evidence for studies assessing interventions for COVID-19 reported in preprints: meta-research study Theodora Oikonomidi, Isabelle Boutron, Olivier Pierre, Guillaume Cabanac, Philippe Ravaud
39 [GO] 2020―Dec―16 Use of short message service in at-home COVID-19 patient management Paul Loubet, Christian Czeschan, Matthieu Sintes, Albert Sotto, Didier Laureillard
40 [GO] 2020―Dec―08 Optimizing COVID-19 surveillance in long-term care facilities: a modelling study David R. M. Smith, Audrey Duval, Koen B. Pouwels, Didier Guillemot, Jérôme Fernandes, Bich-Tram Huynh, et al. (+2)
41 [GO] 2020―Nov―25 Evidence for treatment with estradiol for women with SARS-CoV-2 infection Ute Seeland, Flaminia Coluzzi, Maurizio Simmaco, Cameron Mura, Philip E. Bourne, Max Heiland, et al. (+2)
42 [GO] 2020―Nov―16 Mortality and other adverse outcomes in patients with type 2 diabetes mellitus admitted for COVID-19 in association with glucose-lowering drugs: a nationwide cohort study Luis M. Pérez-Belmonte, José David Torres-Peña, María D. López-Carmona, M. Mar. Ayala-Gutiérrez, Francisco Fuentes-Jiménez, Lucía Jorge Huerta, et al. (+19)
43 [GO] 2020―Nov―10 Comparison of two different frailty measurements and risk of hospitalisation or death from COVID-19: findings from UK Biobank Fanny Petermann-Rocha, Peter Hanlon, Stuart R. Gray, Paul Welsh, Jason M. R. Gill, Hamish Foster, et al. (+11)
44 [GO] 2020―Nov―04 Impact of Covid-19 in pregnancy on mother’s psychological status and infant’s neurobehavioral development: a longitudinal cohort study in China Yuanyuan Wang, Lian Chen, Tianchen Wu, Huifeng Shi, Qin Li, Hai Jiang, et al. (+5)
45 [GO] 2020―Nov―04 At what times during infection is SARS-CoV-2 detectable and no longer detectable using RT-PCR-based tests? A systematic review of individual participant data Sue Mallett, A. Joy Allen, Sara Graziadio, Stuart A. Taylor, Naomi S. Sakai, Kile Green, et al. (+14)
46 [GO] 2020―Oct―29 Ending COVID-19: progress and gaps in research-highlights of the July 2020 GloPID-R COVID-19 Research Synergies Meetings
47 [GO] 2020―Oct―23 Frailty as an integrative marker of physiological vulnerability in the era of COVID-19 Qian-Li Xue
48 [GO] 2020―Oct―22 Reconstructing the early global dynamics of under-ascertained COVID-19 cases and infections Timothy W. Russell, Nick Golding, Joel Hellewell, Sam Abbott, Lawrence Wright, Carl A. B. Pearson, et al. (+7)
49 [GO] 2020―Oct―19 Pregnant women with COVID-19 and risk of adverse birth outcomes and maternal-fetal vertical transmission: a population-based cohort study in Wuhan, China Rong Yang, Hui Mei, Tongzhang Zheng, Qiang Fu, Yiming Zhang, Stephen Buka, et al. (+9)
50 [GO] 2020―Oct―16 Adapting hospital capacity to meet changing demands during the COVID-19 pandemic Ruth McCabe, Nora Schmit, Paula Christen, Josh C. D’Aeth, Alessandra Løchen, Dheeya Rizmie, et al. (+9)
51 [GO] 2020―Oct―14 Response strategies for COVID-19 epidemics in African settings: a mathematical modelling study Kevin van Zandvoort, Christopher I. Jarvis, Carl A. B. Pearson, Nicholas G. Davies, Ruwan Ratnayake, Timothy W. Russell, et al. (+5)
52 [GO] 2020―Oct―09 Response to COVID-19 in South Korea and implications for lifting stringent interventions Amy Dighe, Lorenzo Cattarino, Gina Cuomo-Dannenburg, Janetta Skarp, Natsuko Imai, Sangeeta Bhatia, et al. (+35)
53 [GO] 2020―Oct―05 The impact of COVID-19 control measures on social contacts and transmission in Kenyan informal settlements Matthew Quaife, Kevin van Zandvoort, Amy Gimma, Kashvi Shah, Nicky McCreesh, Kiesha Prem, et al. (+7)
54 [GO] 2020―Sep―12 Correction to: Safety of psychotropic medications in people with COVID-19: evidence review and practical recommendations Giovanni Ostuzzi, Davide Papola, Chiara Gastaldon, Georgios Schoretsanitis, Federico Bertolini, Francesco Amaddeo, et al. (+16)
55 [GO] 2020―Sep―10 Treatment estimands in clinical trials of patients hospitalised for COVID-19: ensuring trials ask the right questions Brennan C. Kahan, Tim P. Morris, Ian R. White, Conor D. Tweed, Suzie Cro, Darren Dahly, et al. (+4)
56 [GO] 2020―Sep―08 Preparing for a pandemic: highlighting themes for research funding and practice-perspectives from the Global Research Collaboration for Infectious Disease Preparedness (GloPID-R) Alice Norton, Louise Sigfrid, Adeniyi Aderoba, Naima Nasir, Peter G. Bannister, Shelui Collinson, et al. (+7)
57 [GO] 2020―Sep―07 The association between frailty and severe disease among COVID-19 patients aged over 60 years in China: a prospective cohort study Yao Ma, Lisha Hou, Xiufang Yang, Zhixin Huang, Xue Yang, Na Zhao, et al. (+5)
58 [GO] 2020―Sep―04 An ecological study of socioeconomic predictors in detection of COVID-19 cases across neighborhoods in New York City Richard S. Whittle, Ana Diaz-Artiles
59 [GO] 2020―Sep―03 COVID-19 length of hospital stay: a systematic review and data synthesis Eleanor M. Rees, Emily S. Nightingale, Yalda Jafari, Naomi R. Waterlow, Samuel Clifford, Carl A. B. Pearson, et al. (+4)
60 [GO] 2020―Aug―21 Compassionate drug (mis)use during pandemics: lessons for COVID-19 from 2009 Amanda M. Rojek, Genevieve E. Martin, Peter W. Horby
61 [GO] 2020―Aug―19 The effect of travel restrictions on the geographical spread of COVID-19 between large cities in China: a modelling study Billy J. Quilty, Charlie Diamond, Yang Liu, Hamish Gibbs, Timothy W. Russell, Christopher I. Jarvis, et al. (+7)
62 [GO] 2020―Aug―19 Considerations for target oxygen saturation in COVID-19 patients: are we under-shooting? Niraj Shenoy, Rebecca Luchtel, Perminder Gulani
63 [GO] 2020―Aug―14 Indirect implications of COVID-19 prevention strategies on non-communicable diseases Pietro A. Modesti, Jiguang Wang, Albertino Damasceno, Charles Agyemang, Luc Van Bortel, Alexandre Persu, et al. (+6)
64 [GO] 2020―Aug―06 Epidemiological and clinical features of pediatric COVID-19 Cheng-Xian Guo, Li He, Ji-Ye Yin, Xiang-Guang Meng, Wei Tan, Guo-Ping Yang, et al. (+4)
65 [GO] 2020―Jul―31 “The post-COVID era”: challenges in the treatment of substance use disorder (SUD) after the pandemic Hugo López-Pelayo, Henri-Jean Aubin, Colin Drummond, Geert Dom, Francisco Pascual, Jürgen Rehm, et al. (+3)
66 [GO] 2020―Jul―30 Impact of lockdown on COVID-19 epidemic in Île-de-France and possible exit strategies Laura Di Domenico, Giulia Pullano, Chiara E. Sabbatini, Pierre-Yves Boëlle, Vittoria Colizza
67 [GO] 2020―Jul―30 Identifying and combating the impacts of COVID-19 on malaria Stephen J. Rogerson, James G. Beeson, Moses Laman, Jeanne Rini Poespoprodjo, Timothy William, Julie A. Simpson, Ric N. Price
68 [GO] 2020―Jul―24 Simulating the effect of school closure during COVID-19 outbreaks in Ontario, Canada Elaheh Abdollahi, Margaret Haworth-Brockman, Yoav Keynan, Joanne M. Langley, Seyed M. Moghadas
69 [GO] 2020―Jul―15 Could hemophagocytic lymphohistiocytosis be the core issue of severe COVID-19 cases? Violetta Opoka-Winiarska, Ewelina Grywalska, Jacek Roliński
70 [GO] 2020―Jul―15 Early epidemiological assessment of the transmission potential and virulence of coronavirus disease 2019 (COVID-19) in Wuhan City, China, January-February, 2020 Kenji Mizumoto, Katsushi Kagaya, Gerardo Chowell
71 [GO] 2020―Jul―15 Polycystic ovary syndrome (PCOS) and COVID-19: an overlooked female patient population at potentially higher risk during the COVID-19 pandemic Ioannis Kyrou, Emmanouil Karteris, Tim Robbins, Kamaljit Chatha, Fotios Drenos, Harpal S. Randeva
72 [GO] 2020―Jul―15 Systems and implementation science should be part of the COVID-19 response in low resource settings Mike English, Mosa Moshabela, Jacinta Nzinga, Edwine Barasa, Benjamin Tsofa, Bruno Marchal, Margaret E Kruk
73 [GO] 2020―Jul―15 Projected geographic disparities in healthcare worker absenteeism from COVID-19 school closures and the economic feasibility of child care subsidies: a simulation study Elizabeth T. Chin, Benjamin Q. Huynh, Nathan C. Lo, Trevor Hastie, Sanjay Basu
74 [GO] 2020―Jul―15 New insights into genetic susceptibility of COVID-19: an ACE2 and TMPRSS2 polymorphism analysis Yuan Hou, Junfei Zhao, William Martin, Asha Kallianpur, Mina K. Chung, Lara Jehi, et al. (+4)
75 [GO] 2020―Jul―15 Safety of psychotropic medications in people with COVID-19: evidence review and practical recommendations Giovanni Ostuzzi, Davide Papola, Chiara Gastaldon, Georgios Schoretsanitis, Federico Bertolini, Francesco Amaddeo, et al. (+16)
76 [GO] 2020―Jul―01 Ethnicity and COVID-19 infection: are the pieces of the puzzle falling into place? Rachel H. Mulholland, Ian P. Sinha
77 [GO] 2020―Jun―29 Forecasting spatial, socioeconomic and demographic variation in COVID-19 health care demand in England and Wales Mark D. Verhagen, David M. Brazel, Jennifer Beam Dowd, Ilya Kashnitsky, Melinda C. Mills
78 [GO] 2020―Jun―25 Rapid publications risk the integrity of science in the era of COVID-19 N. Bagdasarian, G. B. Cross, D. Fisher
79 [GO] 2020―Jun―25 A prospect on the use of antiviral drugs to control local outbreaks of COVID-19 Andrea Torneri, Pieter Libin, Joris Vanderlocht, Anne-Mieke Vandamme, Johan Neyts, Niel Hens
80 [GO] 2020―Jun―25 Why the COVID-19 pandemic should be a call for action to advance equitable access to medicines Jillian C. Kohler, Tim K. Mackey
81 [GO] 2020―Jun―25 COVID-19: a retrospective cohort study with focus on the over-80s and hospital-onset disease Simon E. Brill, Hannah C. Jarvis, Ezgi Ozcan, Thomas L. P. Burns, Rabia A. Warraich, Lisa J. Amani, et al. (+4)
82 [GO] 2020―Jun―25 Addressing challenges for clinical research responses to emerging epidemics and pandemics: a scoping review Louise Sigfrid, Katherine Maskell, Peter G. Bannister, Sharif A. Ismail, Shelui Collinson, Sadie Regmi, et al. (+7)
83 [GO] 2020―Jun―09 COVID-19 cancer conundrum-evidence driving decisions or the lack of it? Nalinie Joharatnam-Hogan, Khurum Khan
84 [GO] 2020―Jun―08 Responding to COVID-19: how an academic infectious diseases division mobilized in Singapore Sophia Archuleta, Gail Cross, Jyoti Somani, Lionel Lum, Amelia Santosa, Rawan A. Alagha, et al. (+26)
85 [GO] 2020―Jun―05 The role of pulmonary CT scans for children during the COVID-19 pandemic Ian P. Sinha, Musa Kaleem
86 [GO] 2020―Jun―03 An evidence mapping and analysis of registered COVID-19 clinical trials in China Liming Lu, Fan Li, Hao Wen, Shuqi Ge, Jingchun Zeng, Wen Luo, et al. (+3)
87 [GO] 2020―Jun―03 Real-time monitoring the transmission potential of COVID-19 in Singapore, March 2020 Amna Tariq, Yiseul Lee, Kimberlyn Roosa, Seth Blumberg, Ping Yan, Stefan Ma, Gerardo Chowell
88 [GO] 2020―Jun―03 Lactate dehydrogenase and susceptibility to deterioration of mild COVID-19 patients: a multicenter nested case-control study Jichan Shi, Yang Li, Xian Zhou, Qiran Zhang, Xinchun Ye, Zhengxing Wu, et al. (+8)
89 [GO] 2020―Jun―03 Heterogenous COVID-19 transmission dynamics within Singapore: a clearer picture of future national responses N. Bagdasarian, D. Fisher
90 [GO] 2020―May―29 Ethnic and socioeconomic differences in SARS-CoV-2 infection: prospective cohort study using UK Biobank Claire L. Niedzwiedz, Catherine A. O’Donnell, Bhautesh Dinesh Jani, Evangelia Demou, Frederick K. Ho, Carlos Celis-Morales, et al. (+6)
91 [GO] 2020―May―28 Diagnosis of COVID-19 in children: the story evolves R. Harwood, I. Sinha
92 [GO] 2020―May―27 Evaluation of the potential incidence of COVID-19 and effectiveness of containment measures in Spain: a data-driven approach Alberto Aleta, Yamir Moreno
93 [GO] 2020―May―25 Epidemiological models are important tools for guiding COVID-19 interventions Robin N. Thompson
94 [GO] 2020―May―22 Africa’s response to COVID-19 Chikwe Ihekweazu, Emmanuel Agogo
95 [GO] 2020―May―07 Quantifying the impact of physical distance measures on the transmission of COVID-19 in the UK Christopher I. Jarvis, Kevin Van Zandvoort, Amy Gimma, Kiesha Prem, Petra Klepac, G. James Rubin, W. John Edmunds
96 [GO] 2020―May―06 A single-center, retrospective study of COVID-19 features in children: a descriptive investigation Huijing Ma, Jiani Hu, Jie Tian, Xi Zhou, Hui Li, Maxwell Thomas Laws, et al. (+6)
97 [GO] 2020―Apr―09 Medical education during pandemics: a UK perspective Areeb Mian, Shujhat Khan
98 [GO] 2020―Mar―18 Coronavirus: the spread of misinformation Areeb Mian, Shujhat Khan
99 [GO] 2020―Mar―13 What further should be done to control COVID-19 outbreaks in addition to cases isolation and contact tracing measures? Zhenjian He
100 [GO] 2020―Feb―28 Q&A: The novel coronavirus outbreak causing COVID-19 Dale Fisher, David Heymann


[de][en]

Last change 2021―Jun―30 20:09:44 UTC

© Daten-Quadrat 2021       Done in 0.005 sec